IDEX Corporation Continues Strategic Capital Deployment with Agreement to Acquire Iridian Spectral Technologies

News Release
April 26, 2023

Northbrook, Illinois, (April 26, 2022) – IDEX Corporation (NYSE:IEX) today announced it has entered into a definitive agreement to acquire Iridian Spectral Technologies (“Iridian”) for cash consideration of 150 million Canadian dollars (“CAD”), subject to customary adjustments. The acquisition complements existing IDEX optical coating expertise, allowing IDEX to expand its core capabilities to support current and future markets.

Iridian is a global leader in designing and manufacturing thin-film, multi-layer optical filters serving the laser communications, telecommunications, and life sciences markets. The purchase is expected to close later this quarter, subject to customary closing conditions, at which point Iridian will join the businesses of IDEX Optical Technologies in IDEX’s Health & Science Technology segment. Iridian will also be a strong partner in the life science filters business driven by the Semrock team of IDEX Health & Science.

“This acquisition strongly supports our strategic growth plan,” IDEX Chief Executive Officer and President Eric Ashleman said. “It expands our talent, technology and product portfolio in optical filters, enabling us to better compete in our core markets, and expand into new markets that we believe will drive profitable growth.”

Iridian has proven expertise in optical filter design and production, providing support throughout a product’s lifecycle, from initial prototyping to high-volume manufacturing. They offer advanced, proprietary thin-film design deposition and manufacturing technology of durable, high-performance filter optics.

Iridian has a strong brand reputation and an established, loyal customer base, which complements the IDEX Optical Technology brands (CVI Laser Optics, CVI Infrared Optics, and Advanced Thin Films) along with the IDEX Health & Science, Semrock optical filters product line.

Privately held and based in Ottawa, Ontario, Canada, Iridian expects fiscal year 2023 sales of approximately CAD 36 million and EBITDA margin in the low 30s.

Use of Non-GAAP Financial Information

IDEX prepares its public financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP). IDEX supplements certain GAAP financial performance metrics with non-GAAP financial performance metrics. Management believes these non-GAAP financial performance metrics provide investors with greater insight, transparency and a more comprehensive understanding of the financial information used by management in its financial and operational decision-making because certain of these non-GAAP metrics exclude items not reflective of ongoing operations. Non-GAAP financial performance metrics should not be considered a substitute for, nor superior to, the financial data prepared in accordance with GAAP. EBITDA is calculated as net income plus interest expense plus provision for income taxes plus depreciation and amortization. EBITDA margin is calculated as EBITDA divided by net sales.

IDEX has not provided a reconciliation of the expected EBITDA margin of Iridian for FY 2023 because we are unable to quantify certain amounts that would be required to be included in Iridian’s contribution to net income without unreasonable efforts. In addition, IDEX believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include statements regarding the expected benefits of the acquisition of Iridian, the expected impact of the acquisition on IDEX’s product offerings or proposed product offerings, the enhancement of IDEX’s business strategy, integration plans, expected growth opportunities, the projected sales and EBITDA margin of Iridian, and the expected timing for the closing of the acquisition. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this press release. The risks and uncertainties include, but are not limited to, the following: levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets and adverse developments affecting the financial services industry; pricing pressures, including inflation and rising interest rates, and other competitive factors and levels of capital spending in certain industries, all of which could have a material impact on order rates and IDEX’s results; the impact of health epidemics and pandemics and terrorist attacks and wars, including the ongoing conflict between Russia and Ukraine, which could have an adverse impact on IDEX’s business by creating disruptions in the global supply chain and by potentially having an adverse impact on the global economy; IDEX’s ability to integrate Iridian and to acquire, integrate and operate other acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which IDEX operates; developments with respect to trade policy and tariffs; interest rates; capacity utilization and the effect this has on costs; labor markets; supply chain backlogs, including risks affecting component availability, labor inefficiencies and freight logistical challenges; market conditions and material costs; risks related to environmental, social and corporate governance issues, including those related to climate change and sustainability; and developments with respect to contingencies, such as litigation and environmental matters. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in IDEX’s most recent annual report on Form 10-K and IDEX’s subsequent quarterly reports filed with the Securities and Exchange Commission (“SEC”) and the other risks discussed in IDEX’s filings with the SEC. The forward-looking statements included here are only made as of the date of this press release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 50 diverse businesses around the world part of the IDEX family. With more than 8,500 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with over $3.1 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit IDEX’s website at www.idexcorp.com.

Investor Contact

IDEX Corporation
Allison Lausas
Vice President and Chief Accounting Officer
+1 847-498-7070
investorrelations@idexcorp.com

Media Contact:

IDEX Corporation
Mark Spencer
+1 847-457-3793
mdspencer@idexcorp.com

IDEX Reports Strong Fourth Quarter and Record Full Year 2022 Results

News Release
January 31, 2023

Fourth Quarter Highlights

(All comparisons against the fourth quarter of 2021 unless otherwise noted)

  • Reported EPS of $1.71, up 10% and adjusted EPS of $2.01, up 18%
  • Orders of $803.4 million, up 1% overall and 1% organically
  • Sales of $810.7 million, up 13% overall and 12% organically
  • Net income of $130.0 million; net income margin of 16.0%, down 60 basis points
  • Adjusted EBITDA of $218.9 million; Adjusted EBITDA margin of 27.0%, up 10 basis points

Full Year Highlights

(All comparisons against full year 2021 unless otherwise noted)

  • Record reported EPS of $7.71, up 31% and record adjusted EPS of $8.12, up 18%
  • Record orders of $3.3 billion, up 8% overall and 5% organically
  • Record sales of $3.2 billion, up 15% overall and 13% organically
  • Net income of $586.7 million; net income margin of 18.4%, up 210 basis points
  • Record Adjusted EBITDA of $884.2 million; Adjusted EBITDA margin of 27.9%, up 20 basis points
  • Invested more than $1 billion for acquisitions, capital projects and share repurchases

“IDEX achieved another record year in 2022, and our teams continue to deliver on multiple fronts,” said
Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “We expanded capacity and
throughput to better meet customer expectations. We applied focused innovation to solve tough problems
for our best customers, driving above-market performance and continued strong price capture while
deploying record capital to bring three high quality growth businesses into the portfolio to support our
future goals.”

“We anticipate 2023 will be an uncertain period of transition as we calibrate with customers to adjust to
compression within the end-to-end order fulfillment cycle as well as broader global macroeconomic shifts.
IDEX faces all of that within a short cycle framework which limits visibility, but supports quick adaptation
and business alignment. We continue to monitor conditions across our diverse portfolio of businesses
and expect to course-correct quickly as conditions warrant. Regardless of market conditions, we believe
IDEX teams are prepared to navigate the challenges and opportunities ahead.”

View full report at: https://www.businesswire.com/news/home/20230131005861/en/IDEX-Reports-Strong-Fourth-Quarter-and-Record-Full-Year-2022-Results

IDEX Corporation Completes Acquisition of Muon Group

News Release
November 18, 2022

Northbrook, Illinois (November 18, 2022) – IDEX Corporation (NYSE:IEX) today announced that it has completed its previously-announced acquisition of micro-precision technology manufacturing company Muon B.V. and its subsidiaries (“Muon Group”).

Based in the Netherlands, Muon Group manufactures highly precise flow paths in a variety of materials that enable the movement of various liquids and gases in critical applications for medical technologies, semiconductor, food processing, digital printing and filtration. The group includes LouwersHanique, Veco, Millux, Tecan and Atul, which have critical technical expertise in precision and tolerances for different materials, from metals and glass to plastics and ceramics.

“The Muon Group companies are an IDEX-like collection of businesses, making precise, highly-engineered solutions for mission-critical applications, with a values-based culture that very much matches ours. I’m pleased to welcome the Muon Group team to the IDEX family,” IDEX Chief Executive Officer and President Eric Ashleman said.

“It’s clear that joining a global manufacturing company like IDEX will give us tremendous opportunities to continue scaling up our growth. Becoming part of the IDEX culture and operating model will give us resources, rigor and colleagues that we believe will help us together achieve even greater things,” said Michiel Barendse, Managing Director of Muon Group.

Muon Group will report into IDEX’s Health & Science Technology (HST) segment.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include statements regarding the expected benefits of the acquisition of Muon Group. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this press release. The risks and uncertainties include, but are not limited to, the following: the impact of health epidemics and pandemics, including the COVID-19 pandemic, and the impact of related governmental actions, on IDEX’s ability to operate its business and facilities, on its customers, on supply chains and on the U.S. and global economy generally; economic and political consequences resulting from terrorist attacks and wars, including Russia’s invasion of Ukraine and the global response to this invasion, which, along with the ongoing effects of the COVID-19 pandemic, could have an adverse impact on IDEX’s business by creating disruptions in the global supply chain and by potentially having an adverse impact on the global economy; levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets; pricing pressures, including inflation and rising interest rates, and other competitive factors and levels of capital spending in certain industries, all of which could have a material impact on order rates and IDEX’s results; IDEX’s ability to integrate the Muon Group and to acquire, integrate and operate other acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which IDEX operates; developments with respect to trade policy and tariffs; interest rates; capacity utilization and the effect this has on costs; labor markets; supply chain backlogs, including risks affecting component availability, labor inefficiencies and freight logistical challenges; market conditions and material costs; risks related to environmental, social and corporate governance (“ESG”) issues, including those related to climate change and sustainability; and developments with respect to contingencies, such as litigation and environmental matters. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in IDEX’s most recent annual report on Form 10-K and IDEX’s subsequent quarterly reports filed with the Securities and Exchange Commission (“SEC”) and the other risks discussed in IDEX’s filings with the SEC. The forward-looking statements included here are only made as of the date of this press release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 8,000 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

Investor Contact:

IDEX Corporation
Allison Lausas

Vice President and Chief Accounting Officer

+1 847-498-7070

investorrelations@idexcorp.com

 

Media Contact:

IDEX Corporation

Mark Spencer

+1 847-457-3793

mdspencer@idexcorp.com

IDEX Reports Record Third Quarter Results and Raises Full Year Guidance

News Release
October 25, 2022

IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended September 30, 2022.

Third Quarter 2022 Highlights

  • Record reported EPS of $2.36, up 56% and record adjusted EPS of $2.14, up 20% vs. Q3 2021
  • Record sales of $824 million, up 16% overall and 15% organically vs. Q3 2021
  • Reported and adjusted operating margin of 24.5% and 24.9% were up 190 and 60 basis points, respectively, vs. Q3 2021
  • Record cash from operations of $198 million was 111% of net income; record free cash flow of $182 million was 112% of adjusted net income
  • Full year GAAP EPS and adjusted EPS raised to $7.75 to $7.80 and $8.04 to $8.09, respectively

View full report at: https://www.businesswire.com/news/home/20221025005893/en/

IDEX Corporation Appoints Katrina L. Helmkamp as Non-Executive Chair; William M. Cook to Retire

Company News
September 22, 2022

Katrina L. Helmkamp, who was appointed Non-Executive Chair of the IDEX Corporation Board of Directors, effective October 1, 2022.

IDEX Corporation (NYSE: IEX) today announced that Katrina L. Helmkamp has been appointed Non-Executive Chair of its Board of Directors, effective October 1, 2022.

Ms. Helmkamp has served as an independent director and member of the IDEX Board since November 2015, and as a member of multiple Board committees, including as Chair of the Nominating and Corporate Governance Committee. As President and CEO of Cartus Corporation, the relocation services subsidiary of Anywhere Real Estate Inc., and in her previous roles as CEO of Lenox Corporation and Vice President Global Refrigeration for Whirlpool Corporation, she has gained extensive global business experience, with operating leadership skills and experience across multiple markets and technologies.

“The impact of IDEX’s highly engineered products used in mission-critical applications can be seen in so many industries worldwide. I am committed to and proud to support IDEX in its continued success,” Ms. Helmkamp said.

Ms. Helmkamp succeeds William M. Cook, who after fourteen years of serving on the IDEX Board has announced his intention to retire. Mr. Cook has been an invaluable contributor to the Board of Directors and the company, serving in various leadership roles including as a member and Chair of the Audit Committee, Lead Director, and most recently, as Non-Executive Chairman of the Board.

Ms. Helmkamp continued, “It is no surprise that the National Association of Corporate Directors (NACD) named Bill Cook its ‘Public Company Director of the Year’ in 2021. His presence will be greatly missed by the Board, and I am honored to continue the work to support IDEX in creating value for shareholders and innovative and valued solutions for customers.”

Mr. Cook noted, “What first attracted me to the IDEX Board of Directors remains there today. It is a world-class Board, bringing together highly intelligent and results-driven business executives in a very collaborative culture, where everyone always brings their ‘best game.’ Katrina is a natural choice to be the next Chair of the Board of Directors. She has what it takes to be an outstanding leader.”

“As we look to the future, I am excited to continue working with Katrina to build on IDEX’s long track record of success,” said Eric D. Ashleman, CEO and President of IDEX Corporation. “I also want to thank Bill, on behalf of the entire organization, for the remarkable leadership and unwavering encouragement he has provided during his 14 years of service on the IDEX Board.”

With Mr. Cook’s departure, effective October 1, 2022, the size of the Board will decrease from 11 to 10 directors.

About IDEX

IDEX Corporation (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 8,000 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

IDEX Corporation’s Capital Deployment Continues with Agreement to Acquire Muon Group

Company News
September 13, 2022

IDEX Corporation (NYSE:IEX) today announced that it has entered into a definitive agreement to acquire micro-precision technology manufacturing company Muon B.V. and its subsidiaries (“Muon Group”) for cash consideration of €700 million.

Based in the Netherlands, Muon Group manufactures highly precise flow paths in a variety of materials that enable the movement of various liquids and gases in critical applications for medical technologies, semiconductor, food processing, digital printing and filtration. The group includes LouwersHanique, Veco, Millux, Tecan and Atul, which have critical technical expertise in precision and tolerances for different materials, from metals and glass to plastics and ceramics.

“Together, the Muon Group will expand upon a growing platform of IDEX precision technology businesses, including those already part of IDEX Health & Science, with unique technology and product solutions for similar end-customers. The commercial synergy potential between our health and science businesses and Muon Group companies will yield expanded offerings to new and existing customers,” IDEX Chief Executive Officer and President Eric Ashleman said. “Muon Group is an IDEX-like business, producing highly engineered products used in mission-critical applications where customers demand exacting quality standards. Their companies are leaders in their fields, and we are excited to welcome them and their outstanding management team to the IDEX family.”

Like IDEX, Muon Group has strong connections to an array of highly innovative, well-known OEMs, working in partnership like members of an extended team to solve some of their most challenging issues. This forms a strong base for ongoing growth through innovation.

“The acquisition of Muon Group demonstrates our disciplined capital deployment strategy that focuses on identifying high-quality technology businesses that will enhance our strategy and we believe will drive long term shareholder value,” Ashleman said. “We expect Muon Group to thrive in our entrepreneurial culture, while our decentralized model fosters decision-making closest to the customer, producing excellent results.”

“All of us at Muon are excited to be joining forces with the IDEX platform as we feel this is the best way to secure our long-term growth ambitions. IDEX’s operating model and culture match ours well, and their scale and resources will help us achieve our targets faster,” Michiel Barendse, CEO of Muon Group said.

Muon Group is privately held by Rivean Capital, a European mid-market private equity firm, which acquired the company in 2018.

With expected FY 2022 sales of approximately €140 million and EBITDA margins of approximately 33 percent, Muon Group will join the Scientific Fluidics & Optics group in IDEX’s Health & Science Technology segment.

The transaction is expected to close in the fourth quarter, subject to regulatory approvals and consultation with the Dutch works council. This acquisition is expected to be funded by IDEX using cash on hand and proceeds from its revolving credit facility.

Use of Non-GAAP Financial Information

IDEX prepares its public financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP). IDEX supplements certain GAAP financial performance metrics with non-GAAP financial performance metrics. Management believes these non-GAAP financial performance metrics provide investors with greater insight, transparency and a more comprehensive understanding of the financial information used by management in its financial and operational decision-making because certain of these non-GAAP metrics exclude items not reflective of ongoing operations. Non-GAAP financial performance metrics should not be considered a substitute for, nor superior to, the financial data prepared in accordance with GAAP. EBITDA is calculated as net income plus interest expense plus provision for income taxes plus depreciation and amortization. EBITDA margin is calculated as EBITDA divided by net sales.

IDEX has not provided a reconciliation of the expected EBITDA or EBITDA margin contribution by Muon Group for FY 2022 because we are unable to quantify certain amounts that would be required to be included in Muon Group’s contribution to net income without unreasonable efforts. In addition, IDEX believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements include statements regarding the expected benefits of the acquisition of Muon Group, the expected impact of the acquisition on IDEX’s product offerings or proposed product offerings, IDEX’s combined existing and new customers, the enhancement of IDEX’s business strategy, integration plans, the expected growth opportunities and synergies resulting from the acquisition, IDEX’s ability to achieve its targets, the anticipated long term value to IDEX’s shareholders, the projected earnings of the Muon Group and the related impact on IDEX’s earnings, and the expected timing and funding for the closing of the acquisition. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this press release. The risks and uncertainties include, but are not limited to, the following: the impact of health epidemics and pandemics, including the COVID-19 pandemic, and the impact of related governmental actions, on IDEX’s ability to operate its business and facilities, on its customers, on supply chains and on the U.S. and global economy generally; economic and political consequences resulting from terrorist attacks and wars, including Russia’s invasion of Ukraine and the global response to this invasion, which, along with the ongoing effects of the COVID-19 pandemic, could have an adverse impact on IDEX’s business by creating disruptions in the global supply chain and by potentially having an adverse impact on the global economy; levels of industrial activity and economic conditions in the U.S. and other countries around the world, including uncertainties in the financial markets; pricing pressures, including inflation and rising interest rates, and other competitive factors and levels of capital spending in certain industries, all of which could have a material impact on order rates and IDEX’s results; IDEX’s ability to integrate the Muon Group and to acquire, integrate and operate other acquired businesses on a profitable basis; the relationship of the U.S. dollar to other currencies and its impact on pricing and cost competitiveness; political and economic conditions in foreign countries in which IDEX operates; developments with respect to trade policy and tariffs; interest rates; capacity utilization and the effect this has on costs; labor markets; supply chain backlogs, including risks affecting component availability, labor inefficiencies and freight logistical challenges; market conditions and material costs; risks related to environmental, social and corporate governance (“ESG”) issues, including those related to climate change and sustainability; and developments with respect to contingencies, such as litigation and environmental matters. Additional factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” section included in IDEX’s most recent annual report on Form 10-K and IDEX’s subsequent quarterly reports filed with the Securities and Exchange Commission (“SEC”) and the other risks discussed in IDEX’s filings with the SEC. The forward-looking statements included here are only made as of the date of this press release, and management undertakes no obligation to publicly update them to reflect subsequent events or circumstances, except as may be required by law. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.

About IDEX

IDEX Corporation (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 8,000 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

IDEX Reports Strong Second Quarter Results

News Release
July 26, 2022

IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended June 30, 2022.

Second Quarter 2022 Highlights

  • Reported EPS of $1.81, up 35% and record adjusted EPS of $2.02, up 15% vs. Q2 2021
  • Orders of $839 million, up 12% overall and 7% organically vs. Q2 2021
  • Record sales of $796 million, up 16% overall and 12% organically vs. Q2 2021
  • Reported operating margin of 23.4%, up 30 basis points vs. Q2 2021
  • Completed acquisition of KZValve on May 2, 2022
  • Full year GAAP EPS guidance raised to $7.19 to $7.29 from prior guidance of $6.87 to $7.00
  • Full year adjusted EPS guidance raised to $7.88 to $7.98 from prior guidance of $7.50 to $7.63

View full report at: https://investors.idexcorp.com/news-releases/news-release-details/idex-reports-strong-second-quarter-results

IDEX Corporation Appoints Alejandro Quiroz Centeno to Board of Directors

Company News
June 16, 2022

IDEX Corporation (NYSE:IEX) today announced the appointment of Alejandro Quiroz Centeno to the company’s Board of Directors. The appointment of Mr. Quiroz, effective June 15, 2022, increases the size of the board from 10 to 11 directors. He will serve on the board’s Compensation Committee.

IDEX Corporation

Mr. Quiroz currently serves as CEO Latin America for Prysmian Group, a global leader in the energy and telecommunications cable systems industry. Prior to joining Prysmian Group, Mr. Quiroz served as President, Aptiv Latin America, leading a $5.5 billion automotive technology business with 75,000 employees and 40 locations in Mexico, Central and South America. His previous experience includes leadership roles in various countries at automotive suppliers Tenneco, Edscha AG and Continental AG, as well as home appliance manufacturer Whirlpool.

“Now that more than half of IDEX revenue comes from outside the United States, we look forward to the perspective and insight that Alejandro will bring based on his significant experience leading international manufacturing organizations,” said IDEX Chief Executive Officer and President Eric D. Ashleman. “He has a strong track record of leveraging applied technologies into long-term competitive advantage within a variety of industries and geographies and will be an ideal fit for IDEX.”

Mr. Quiroz holds a Master of Business Administration degree from the University of Michigan Ross School of Business, and a Bachelor of Science degree in Mechanical Engineering from Universidad de las Americas-Puebla. He is a member of the US-Mexico Foundation and the Latino Corporate Directors Association.

“Alejandro has deep current business experience in markets all over the world, which will bring great value to our board. He will be an excellent addition to an already strong Board of Directors,” said William M. Cook, Non-Executive Chairman of the Board.

About IDEX

IDEX (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 7,500 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

View source version on businesswire.comhttps://www.businesswire.com/news/home/20220616005193/en/

IDEX Corporation Adds Precision Farming Solutions for Agriculture & Industrial Applications With Completion of KZValve Acquisition

News Release
May 2, 2022

IDEX Corporation (NYSE:IEX) today announced that it has completed its previously-announced acquisition of KZValve, LLC, bolstering IDEX’s expertise in providing critical solutions for agriculture and industrial applications.

The acquisition augments and expands upon the current fluid management solutions for the agricultural product market from Banjo Corporation, a unit of IDEX. KZValve creates and manufactures a variety of precision farming components including waterproof motorized valves, manifolds, controllers, and other accessories.

“The addition of KZValve to our agriculture offerings is part of the IDEX growth strategy of investing in innovative businesses with secular growth tailwinds,” IDEX Chief Executive Officer and President Eric Ashleman said. “We look forward to welcoming KZValve team members to the IDEX family of businesses, working together to build upon our portfolio of products, and empowering OEMs and farmers to more efficiently and effectively produce crops to feed the world.”

KZValve is now part of the Agriculture group within IDEX’s Fluid & Metering Technologies (FMT) segment.

 

About IDEX

IDEX (NYSE: IEX) makes thousands of products and mission-critical components that improve everyday life all around you. If you enjoy chocolate, it quite possibly passed through a Viking® internal gear pump at the candy factory. If you were ever in a car accident, emergency workers may have used the Hurst Jaws of Life® rescue tool to save your life. If your doctor ordered a DNA test to predict your risk of disease or determine a course of treatment, the lab may have used equipment containing components made by IDEX Health & Science. Founded in 1988 with three small, entrepreneurial manufacturing companies, we’re proud to say that we now call over 45 diverse businesses around the world part of the IDEX family. With more than 7,500 employees and manufacturing operations in more than 20 countries, IDEX is a high-performing, global company with nearly $2.8 billion in annual sales, committed to making trusted solutions that improve lives. IDEX shares are traded on the New York Stock Exchange under the symbol “IEX”.

For further information on IDEX Corporation and its business units, visit the company’s website at www.idexcorp.com.

IDEX Reports Record First Quarter Results

News Release
April 26, 2022

IDEX Corporation (NYSE: IEX) today announced its financial results for the three month period ended March 31, 2022.

First Quarter 2022 Highlights

  • Record reported EPS of $1.83, up 24% and record adjusted EPS of $1.96, up 21% vs. Q1 2021
  • Record orders of $856 million, up 20% overall and 16% organically vs. Q1 2021
  • Record sales of $751 million, up 15% overall and 12% organically vs. Q1 2021
  • Record reported operating margin of 25.0%, up 110 basis points vs. Q1 2021
  • Completed acquisition of Nexsight, LLC on February 28, 2022
  • Announced upcoming acquisition of KZValve

View full report at: https://investors.idexcorp.com/news-releases/news-release-details/idex-reports-record-first-quarter-results

WordPress Lightbox